Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome

Journal of Neuroinflammation

Volumn 13, Issue 1, 2016, Pages

  Sabater, Lidia ^a   Planagumà, Jesús ^a   Dalmau, Josep ^a,c,d   Graus, Francesc ^a,b  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Autoantibodies; IgLON5; Immunoglobulin subclasses; Tauopathy

Indexed keywords

EPITOPE; GLYCOPEPTIDASE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G4; NERVE CELL ADHESION MOLECULE; HLA DRB1 ANTIGEN; IGLON5 PROTEIN, HUMAN; IMMUNOGLOBULIN F(AB) FRAGMENT;

ANIMAL CELL; ANTI IGLON5 SYNDROME; ARTICLE; BLOOD ANALYSIS; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CULTURE MEDIUM; EMBRYO; FLOW CYTOMETRY; GENETIC TRANSFECTION; GLYCOSYLATION; HIPPOCAMPUS; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOGENICITY; IMMUNOREACTIVITY; INTERNALIZATION; MOLECULAR RECOGNITION; NERVE CELL CULTURE; NONHUMAN; PATHOGENICITY; PROTEIN DOMAIN; PROTEIN PURIFICATION; RAT; TAUOPATHY; ANIMAL; AUTOIMMUNE DISEASE; BLOOD; CELL CULTURE; CHEMISTRY; CLASSIFICATION; CYTOLOGY; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HEK293 CELL LINE; IMMUNOLOGY; METABOLISM; MUTATION; NERVE CELL; NEWBORN; PATHOLOGY; TIME FACTOR;

ANIMALS; ANIMALS, NEWBORN; AUTOIMMUNE DISEASES; CELL ADHESION MOLECULES, NEURONAL; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOSYLATION; HEK293 CELLS; HIPPOCAMPUS; HLA-DRB1 CHAINS; HUMANS; IMMUNODOMINANT EPITOPES; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN G; MUTATION; NEURONS; RATS; TIME FACTORS; TRANSFECTION;

EID: 84984860945     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/s12974-016-0689-1     Document Type: Article

References (21)

1. Sabater L, Gaig C, Gelpi E, Bataller L, Lewerenz J, Torres-Vega E, et al. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study. Lancet Neurol. 2014;13:575-86.
2. Simabukuro MM, Sabater L, Adoni T, Cury RG, Haddad MS, Moreira CH, et al. Sleep disorder, chorea, and dementia associated with IgLON5 antibodies. Neurol Neuroimmunol Neuroinflamm. 2015;2:e136.
3. Högl B, Heidbreder A, Santamaria J, Graus F, Poewe W. IgLON5 autoimmunity and abnormal behaviours during sleep. Lancet. 2015;385:1590.
4. Brüggemann N, Wandinger KP, Gaig C, Sprenger A, Junghanns K, Helmchen C, et al. Dystonia, lower limb stiffness, and upward gaze palsy in a patient with IgLON5 antibodies. Mov Disord. 2016. doi: 10.1002/mds.26608.
5. Eisenhaber B, Bork P, Eisenhaber F. Sequence properties of GPI-anchored proteins near the omega-site: constraints for the polypeptide binding site of the putative transamidase. Protein Eng. 1998;11:1155-61.
6. Hughes EG, Peng X, Gleichman AJ, et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci. 2010;30:5866-75.
7. Buchhalter JR, Dichter MA. Electrophysiological comparison of pyramidal and stellate nonpyramidal neurons in dissociated cell culture of rat hippocampus. Brain Res Bull. 1991;26:333-8.
8. Moscato EH, Peng X, Jain A, Parsons TD, Dalmau J, Balice-Gordon RJ. Acute mechanisms underlying antibody effects in anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol. 2014;76:108-19.
9. Hashimoto T, Maekawa S, Miyata S. IgLON cell adhesion molecules regulate synaptogenesis in hippocampal neurons. Cell Biochem Funct. 2009;27:496-8.
10. Karagogeos D. Neural GPI-anchored cell adhesion molecules. Front Biosci. 2003;8:s1304-20.
11. Hashimoto T, Yamada M, Maekawa S, Nakashima T, Miyata S. IgLON cell adhesion molecule Kilon is a crucial modulator for synapse number in hippocampal neurons. Brain Res. 2008;1224:1-11.
12. Sanz R, Ferraro GB, Fournier AE. IgLON cell adhesion molecules are shed from the cell surface of cortical neurons to promote neuronal growth. J Biol Chem. 2015;290(7):4330-42.
13. Minhas HM, Pescosolido MF, Schwede M, et al. An unbalanced translocation involving loss of 10q26.2 and gain of 11q25 in a pedigree with autism spectrum disorder and cerebellar juvenile pilocytic astrocytoma. Am J Med Genet A. 2013;161:787-91.
14. Sellar GC, Watt KP, Rabiasz GJ, et al. OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer. Nat Genet. 2003;34:337-43.
15. Ohkawa T, Fukata Y, Yamasaki M, et al. Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors. J Neurosci. 2013;33:18161-74.
16. Ohta K, Shigemoto K, Fujinami A, Maruyama N, Konishi T, Ohta M. Clinical and experimental features of MuSK antibody positive MG in Japan. Eur J Neurol. 2007;14:1029-34.
17. Ng JK, Malotka J, Kawakami N, et al. Neurofascin as a target for autoantibodies in peripheral neuropathies. Neurology. 2012;79:2241-8.
18. Labasque M, Hivert B, Nogales-Gadea G, Querol L, Illa I, Faivre-Sarrailh C. Specific contactin N-glycans are implicated in neurofascin binding and autoimmune targeting in peripheral neuropathies. J Biol Chem. 2014;289:7907-18.
19. Huijbers MG, Querol LA, Niks EH, et al. The expanding field of IgG4-mediated neurological autoimmune disorders. Eur J Neurol. 2015;22:1151-61.
20. Peng X, Hughes EG, Moscato EH, Parsons TD, Dalmau J, Balice-Gordon RJ. Cellular plasticity induced by anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor encephalitis antibodies. Ann Neurol. 2015;77:381-98.
21. Leypoldt F, Armangue T, Dalmau J. Autoimmune encephalopathies. Ann N Y Acad Sci. 2015;1338:94-114.